Navigation Links
Nanoparticles loaded with bee venom kill HIV
Date:3/8/2013

nothing to stop initial infection, and some strains of the virus have found ways around these drugs and reproduce anyway.

"We are attacking an inherent physical property of HIV," Hood says. "Theoretically, there isn't any way for the virus to adapt to that. The virus has to have a protective coat, a double-layered membrane that covers the virus."

Beyond prevention in the form of a vaginal gel, Hood also sees potential for using nanoparticles with melittin as therapy for existing HIV infections, especially those that are drug-resistant. The nanoparticles could be injected intravenously and, in theory, would be able to clear HIV from the blood stream.

"The basic particle that we are using in these experiments was developed many years ago as an artificial blood product," Hood says. "It didn't work very well for delivering oxygen, but it circulates safely in the body and gives us a nice platform that we can adapt to fight different kinds of infections."

Since melittin attacks double-layered membranes indiscriminately, this concept is not limited to HIV. Many viruses, including hepatitis B and C, rely on the same kind of protective envelope and would be vulnerable to melittin-loaded nanoparticles.

While this particular paper does not address contraception, Hood says the gel easily could be adapted to target sperm as well as HIV. But in some cases people may only want the HIV protection.

"We also are looking at this for couples where only one of the partners has HIV, and they want to have a baby," Hood says. "These particles by themselves are actually very safe for sperm, for the same reason they are safe for vaginal cells."

While this work was done in cells in a laboratory environment, Hood and his colleagues say the nanoparticles are easy to manufacture in large enough quantities to supply them for future clinical trials.


'/>"/>

Contact: Julia Evangelou Strait
straitj@wustl.edu
314-286-0141
Washington University School of Medicine
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Researchers show that lipid nanoparticles are ideal for delivering genes and drugs
2. New electrically-conductive polymer nanoparticles can generate heat to kill colorectal cancer cells
3. UGA researchers boost efficacy of drugs by using nanoparticles to target powerhouse of cells
4. Nanoparticles detect biochemistry of inflammation
5. Improved nanoparticles deliver drugs into brain
6. UCSB scientists examine effects of manufactured nanoparticles on soybean crops
7. New nanoparticles shrink tumors in mice
8. Researchers find gold nanoparticles capable of unzipping DNA
9. Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
10. Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells
11. Launch of CouponCanny.com Pre-loaded with Coupon Codes and Deals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nanoparticles loaded with bee venom kill HIV
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... frozen plasma are being used inappropriately, states a commentary ... ) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj081933.pdf . There ... of red blood cells and platelets but not enough ... "Two recent studies in Canada found that 45% ...
... ... the counter medical products has signed a 6 year deal with international super bantam weight ... in the Philippines , ... -- The company’s flagship product, a lotion called Elmore Oil ( www.elmoreoil.com.au ), ...
... informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel , ... in adults. Furthermore, the authorities in Paraguay and Azerbaijan have approved ... Paraguay and Azerbaijan . , ... ...
... ST. PAUL (March 15, 2010) Researchers at the University ... may, over the long term, protect the hearts of ... common form of muscular dystrophy in children. The chemical, ... seeks out tiny cuts in diseased heart muscle. When ...
... , MISSISSAUGA, ON , March 15 /PRNewswire-FirstCall/ ... company focused on the research and development of drug products ... topical and transdermal drug delivery technologies, and on the development ... it has enrolled the first patient in its European Phase ...
... of Dermatology, researchers report that in the United States, melanoma ... in the population 65 years and older. The incidence of ... have the highest rate of mortality. Epidemiologists say that one in ... lifetime, in contrast to one in 1,500 persons in the 1930s. ...
Cached Medicine News:Health News:Filipino World Champion Endorses Charity to Help Fight Child Poverty 2Health News:Filipino World Champion Endorses Charity to Help Fight Child Poverty 3Health News:Yondelis(R) Receives Five New Approvals Outside the European Economic Area 2Health News:Yondelis(R) Receives Five New Approvals Outside the European Economic Area 3Health News:Yondelis(R) Receives Five New Approvals Outside the European Economic Area 4Health News:Researchers discover chemical that may protect hearts of muscular dystrophy patients 2Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 2Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 3Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 4Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 5Health News:Late-stage melanoma results in economic burden 2
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ... the "Dental Consumables Market - Global Industry ... - 2018" report to their offering. ... ) Dental consumables are products which are ... impairments, for tooth restoration and in treatment of ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading ... company, awarded several new IT value-added reseller (VAR) ... hospital organizations with IT goods and services at ... agreements, as well as value-added services such as ... New Novation agreements were awarded to ...
(Date:1/15/2014)... DUBLIN , January 15, 2014 ... that it has waived the Office of Fair Trading (OFT) ... the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).   ... no longer conditional on OFT approval, and Shire expects to ... currently scheduled expiration time, subject to the satisfaction of all ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... To Be Presented at American Association of Immunologists ... 2008 ,Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... may be a useful treatment for type 1 ... American Association,of Immunologists meeting in San Diego, California ...
... DEARBORN, Mich., April 7, 2008 Wayne State,University ... implanted a new device designed to combat congestive ... become a leading tool in,the arsenal to combat ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080407/DC18745 ), The April ...
Cached Medicine Technology:Rigel's R788 Shows Preclinical Activity in Type 1 Diabetes Model 2Rigel's R788 Shows Preclinical Activity in Type 1 Diabetes Model 3Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure 2Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure 3Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: